============
Chemotherapy
============


Targeted cancer therapy
=======================
표적항암제

Epidermal Growth Factor Receptor(EGFR) inhibitors
#################################################
`상피세포 성장인자 수용체 억제 약제 <https://www.cancer.org/cancer/non-small-cell-lung-cancer/treating/targeted-therapies.html>`_

- 이레사
- 타세바
- 지오트립

PD1/PD-L1 inhibitors
####################
`면역 표적항암제 억제 약제 <https://nyulangone.org/conditions/non-small-cell-lung-cancer/treatments/chemotherapy-targeted-drugs-for-lung-cancer>`_

PD-1
^^^^
- Nivolumab (옵디보; Opdivo)
- Pembrolizumab (키트루다; Keytruda)

.. figure:: /images/chemotherapy/opdivo_for_NSCLC.png
	:scale: 25%
	:align: center
	:alt: alternate text
	:figclass: align-center


Recently permitted chemo for non-small cell lung cancer
#######################################################
- 타그리쏘(Osimertinib)
- 올리타(Olmutinib)
- 자이카디아(Ceritinib)
- 알레센사(Alectinib)
- 옵디보(Nivolumab)
- 키트루다(Pembrolizumab)
- 포트라자(Necitumumab)

.. note::

	- 약제 반응이 좋은 환자들을 구별할 수 있는 검사 실시 후 치료여부 결정

		- 타그리쏘/올리타: EGFR 유전자 돌연변이 검사
		- 키트루다: PD-L1 검사

	- Does have side effects
	- Expensive. 초기에는 보험급여 대상이 되지 않음



--------

Side effect
===========
피부발진, 설사

.. figure:: /images/chemotherapy/chemo_side_effect.jpg
   :align: center
   :alt: alternate text
   :figclass: align-center
